Name: MEDIPHARM LABS CORP (LABS) Stock
Brand: MEDIPHARM LABS CORP
Rating: 2.5 (3 reviews)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

Show Percentage Diff	TTM (2025-6-30)	2024 (2024-12-31)	2023 (2023-12-31)	2022 (2022-12-31)	2021 (2021-12-31)
Revenue	44.45M	41.96M	33.06M	22.10M	21.70M
Gross Premiums Earned	null	null	null	null	null
Loss Claims	null	null	null	null	null
Deferred Policy Acquisition Expense	null	null	null	null	null
Net Interest Income	null	null	null	null	null
Non Interest Income	null	null	null	null	null
Loan Loss Provision	null	null	null	null	null
Net Interest Income after Provision	null	null	null	null	null
Non Interest Expense	null	null	null	null	null
Minority Interest Expense	null	null	null	null	0
Cost Of Goods	31.72M	30.23M	29.07M	24.00M	37.00M
Gross Profit	12.74M	11.73M	3.99M	-1.90M	-15.20M
Operating Expenses	23.00M	23.37M	23.60M	27.40M	35.80M
Research and Development	285.00K	235.00K	209.00K	1.00M	1.40M
Selling, General, and Administrative Expenses	22.67M	22.77M	22.87M	23.90M	29.80M
Operating Income	-10.26M	-11.64M	-19.61M	-29.20M	-51.10M
Interest Income/Expense	95.00K	170.00K	19.00K	200.00K	-4.10M
Other Income/Expense	null	null	null	null	null
Non Recurring Items	1.51M	775.00K	6.24M	-1.00M	500.00K
Income Before Taxes	-8.66M	-10.69M	-13.36M	-30.00M	-54.70M
Income Tax	null	0	-276.00K	0	100.00K
Net Income	-8.66M	-10.69M	-13.08M	-30.00M	-54.80M
EBITDA	-8.34M	-9.04M	-17.10M	-26.33M	-45.47M

Per Share Data
EPS Diluted Total Ops	-0.021	-0.0262	-0.036	-0.11	-0.22
Non GAAP EPS	-0.031	-0.04	-0.04	-0.11	-0.23

Statistics
Gross Profit Margin	28.65%	27.96%	12.06%	-8.60%	-70.05%
Profit Margin	-19.47%	-25.49%	-39.57%	-135.75%	-252.53%
Operating Profit Margin	-23.08%	-27.74%	-59.32%	-132.13%	-235.48%

All data in CAD

MEDIPHARM LABS CORP (LABS.CA) Stock Income Statement

Charts